Navigation Links
Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments

Addiction can lead to hospitalization and drug withdrawal

CHICAGO, May 15, 2007 /PRNewswire/ -- A new survey of hundreds of migraine patients and physicians commissioned by the National Headache Foundation and conducted by Harris Interactive shows that 20 percent of migraine patients are currently taking potentially addictive medications that contain barbiturates or opioids and have not been approved by the U.S. Food and Drug Administration for the relief of migraines.

Migraines affect nearly 30 million Americans, according to the National Headache Foundation.

The survey also shows that patients taking prescription medications not approved by the FDA to treat migraines are more likely to experience drug-related side effects than patients taking prescription medications that have been approved by the FDA as migraine treatments.

"It's important for physicians, especially primary care physicians, who most often treat migraine patients, to be aware that medications containing opioids or barbiturates have the potential to produce drug dependence and addictive behavior, especially with regular use," said Richard B. Lipton, M.D., professor and vice chair of neurology at the Albert Einstein College of Medicine in New York City and director of the Montefiore Headache Center. "FDA-approved medications such as triptans are specifically targeted to treat migraine pain and associated symptoms and have a far better safety profile."

The survey of 502 patients and 201 primary care physicians and neurologists conducted earlier this year found that 53 percent of migraine patients take triptans as the primary prescription medication for their condition, but 20 percent take barbiturates or opioids. Another 27 percent take other medications.

Not All Migraine Treatments Are Equal

Triptans stop a migraine attack after the attack begins by stimulating serotonin, which reduces inflammation and
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
2. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
3. NuPathe Reports Positive Phase One Results for NP101 Transdermal Therapy for Acute Migraine
4. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
5. Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both Traditional and Non-traditional Migraine Symptoms
6. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks
7. Addex Reports Positive Results in Phase IIa Clinical Trial With ADX10059 in Migraine
8. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
9. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
10. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:5/17/2013)... , May 17, 2013 Sinovac Biotech Ltd. (Nasdaq: ... China , today announced that it will ... March 31, 2013, before market on Tuesday, May 28, 2013.  ... 28, 2013, at 8:00 a.m. EDT (May 28, 2013 at ... results and provide an update on recent corporate developments. ...
(Date:5/16/2013)... , May 17, 2013 ... and Switzerland,s Cytos Biotechnology AG today ... a Phase 1 clinical trial with their H1N1 influenza vaccine ... technology. In this first Phase 1 clinical trial, the safety ... to protect against H1N1 influenza infection will be evaluated. ...
(Date:5/16/2013)...  PTC Therapeutics, Inc., today announced that it has ... U.S. Securities and Exchange Commission ("SEC") relating to the ... number of shares to be offered and the price ... (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) J.P. ... managers for the offering. Cowen and Company is acting ...
Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... Mich., Jan. 23, 2012 Perrigo Company (Nasdaq: PRGO;TASE) announced ... Administration (FDA) an Abbreviated New Drug Application (ANDA) for azelastine ... the owner of the New Drug Application (NDA) of its ... Impax Laboratories, Inc. (Nasdaq: IPXL ), who will ...
... (OTC: PLCSF), a company focused on innovative medical device ... in the CIN-RG trial, the company,s pivotal trial to ... System™ in the prevention of Contrast-Induced Nephropathy (CIN).  This ... regulatory approval by the U.S. Food and Drug Administration ...
Cached Medicine Technology:Perrigo Confirms Filing for Generic Version of Astepro® Nasal Spray and Announcement of Patent Infringement Lawsuit by Meda Pharmaceuticals 2Perrigo Confirms Filing for Generic Version of Astepro® Nasal Spray and Announcement of Patent Infringement Lawsuit by Meda Pharmaceuticals 3First Patient Treated in PLC Systems' RenalGuard® U.S. Pivotal Trial 2First Patient Treated in PLC Systems' RenalGuard® U.S. Pivotal Trial 3
(Date:5/20/2013)... (PRWEB) May 20, 2013 A novel service ... Clinic . The company has been in the field of ... initiative will make sure that scholars are able to maintain ... service has three stages and has been priced at $1000. ... a dedicated mentor assigned to the project, who will handle ...
(Date:5/20/2013)... Inspired by her client’s total weight loss ... , Shanna Layne came up with the charity idea “Our ... business host a clothing drive to support a local ... worth of clothing to Something Special, the local Montgomery County ... was a huge success. , Being a huge advocate and ...
(Date:5/20/2013)... The report, "Gluten-Free Products Market ... Baking Mixes & Flour, Meat & Poultry Products), ... Global Trends & Forecasts To 2018" defines and ... and forecasting of the global revenue and volume ... and restraining factors for the global gluten-free product ...
(Date:5/20/2013)... Nordic Naturals®, the leading manufacturer of omega-3 ... powerful EPA-only concentrates available without a prescription. With 1600 ... serving, EPA Elite provides high intensity, therapeutic support for ... anti-inflammatory pathways. , EPA Elite is an EPA-only ... to a much-studied ethyl-ester EPA formulation. This dose of ...
(Date:5/20/2013)... My Fit Foods continues its ... location bringing the healthy grab and go concept to the ... Foods store, located at 7979 N. Macarthur Blvd. Suite 110, ... snacks for the taking. , My Fit Foods was founded ... Mendias, a former Marine and Houston personal trainer who was ...
Breaking Medicine News(10 mins):Health News:Dissertation Clinic Prescribes Customized Remedy for Researchers 2Health News:Spring and The Woodlands Personal Training Centers Held Successful “Our Loss Their Gain” Clothing Drive to Help Local Women’s Center 2Health News:Spring and The Woodlands Personal Training Centers Held Successful “Our Loss Their Gain” Clothing Drive to Help Local Women’s Center 3Health News:Gluten-Free Products Market to Reach $6,206.2 Million by 2018 at a CAGR of 10.2% - New Report by MarketsandMarkets 2Health News:Gluten-Free Products Market to Reach $6,206.2 Million by 2018 at a CAGR of 10.2% - New Report by MarketsandMarkets 3Health News:Nordic Naturals Launches Innovative EPA Elite™ 2Health News:My Fit Foods Opens a New Retail Location in Las Colinas Thursday, May 23rd 2
... targeted therapy against the BRAF/MAPK pathway with immunotherapy shows ... of melanoma, according to results of a preclinical study ... the American Association for Cancer Research. "Our results ... therapy and immunotherapy in the treatment of this most ...
... Center in Hamburg, Germany successfully used transcatheter valve-in-valve implantation ... mitral position. This minimally invasive procedure was used ... at high surgical risk. Full details of the ... Catheterization and Cardiovascular Interventions , a journal published by ...
... more likely to underestimate their preschool children,s weight when ... or gaining weight too fast, a study by the ... The study, published online earlier this ... not hesitate to wield their influence in helping parents ...
... ... holistically reverse symptoms associated with Polycystic Ovarian Syndrome and Insulin Resistance in her e-book. ... (PRWEB) ... are now able to lose weight and achieve hormonal balance without taking any prescription ...
... male-only protein found in rats helps control stress signals in ... -- When it comes to stress, women are twice as ... and/or post-traumatic stress, and now a new study in rats ... evidence in animals that suggests that males benefit from having ...
... Journal of Thoracic Oncology features a study aimed ... nab-paclitaxel with carboplatin as a first-line therapy in patients ... researchers with a data needed to guide a phase ... for patients with NSCLC is carboplatin plus solvent-based paclitaxel. ...
Cached Medicine News:Health News:Combined BRAF-targeted and immunotherapy shows promise for melanoma treatment 2Health News:Elderly patients in need of heart valve replacements have alternative to surgery 2Health News:Pediatricians can help parents recognize overweight preschoolers 2Health News:Pediatricians can help parents recognize overweight preschoolers 3Health News:Women with Polycystic Ovarian Syndrome and Insulin Resistance can Lose Weight and Balance Hormones Naturally with Katie Humphrey's New E-book 2Health News:Females May Be Naturally More Prone to Stress: Animal Study 2Health News:Novel paclitaxel formulation encouraging for treating advanced lung cancer 2
... provides anterior column support for single or ... to L5. The system consists of one ... that are stacked to a desired height, ... Fiber Reinforced Polymer material emulates the biomechanical ...
... in interbody fusion are to ... restore disc space height and ... an enviroment for bone fusion ... Allograft is designed to promote ...
... highly adaptable and therefore suitable for a ... its extraordinary small outer diameter and the ... a simple but secure and reliable fixation ... instruments around the corner. These characteristics make ...
A new flexible endoscope with an ultra dense optic fiber system. Its two working and irrigation channels and steering mechanism makes it ideal for a multipurpose use in neurosurgical endoscopy i.e. V...
Medicine Products: